The D3 dopamine receptor: Neurobiology and potential clinical relevance

Pharmacological Reviews

Volumn 49, Issue 3, 1997, Pages 231-252

  Levant, Beth ^a  

^a UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 DIPROPYLAMINO 5 METHOXY 1 METHYLTETRALIN; 2 DIPROPYLAMINO 7 HYDROXYTETRALIN; 3,4,4A,10B TETRAHYDRO 4 PROPYL 2H,5H [1]BENZOPYRANO[4,3 B][1,4]OXAZIN 9 OL; 5 METHOXY 1 METHYL 2 PROPYLAMINOTETRALIN; 7 DIPROPYLAMINO 2,3,5,6,7,8 HEXAHYDRONAPHTHO[2,3 B]FURAN; AMISULPRIDE; APOMORPHINE; BROMOCRIPTINE; BUTACLAMOL; CLOZAPINE; DOMPERIDONE; DOPAMINE; DOPAMINE 3 RECEPTOR; DOPAMINE 3 RECEPTOR BLOCKING AGENT; DOPAMINE 3 RECEPTOR STIMULATING AGENT; EMONAPRIDE; ETICLOPRIDE; HALOPERIDOL; LIGAND; NAFADOTRIDE; PIMOZIDE; PRAMIPEXOLE; PROPYLNORAPOMORPHINE; QUINELORANE; QUINPIROLE; RACLOPRIDE; RISPERIDONE; SPIPERONE; SULPIRIDE; UNINDEXED DRUG; DOPAMINE 2 RECEPTOR; DRD3 PROTEIN, HUMAN; MESSENGER RNA;

ALLELE; ANIMAL TISSUE; CONTROLLED STUDY; DOPAMINE METABOLISM; DRUG DEPENDENCE; DRUG RECEPTOR BINDING; GENETIC LINKAGE; HUMAN; HUMAN TISSUE; MESSENGER RNA SYNTHESIS; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; PSYCHOSIS; RAT; RECEPTOR AFFINITY; RECEPTOR DENSITY; REVIEW; SCHIZOPHRENIA; SIGNAL TRANSDUCTION; ANIMAL; BRAIN; DRUG EFFECT; GENETICS; MENTAL DISEASE; METABOLISM; PHYSIOLOGY;

ANIMALS; BRAIN; HUMANS; MENTAL DISORDERS; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D3; RNA, MESSENGER; SIGNAL TRANSDUCTION;

EID: 0030610305     PISSN: 00316997     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (220)

1. 3 dopamine receptor gene is associated with hyperactivity in mice. Proc. Natl. Acad. Sci. USA 93: 1945-1949, 1996.
2. 3 receptor ligands. Eur. J. Pharmacol. 281: R7-R9, 1995.
3. 3 receptor ligand 7-OH-DPAT on male rat ejaculatory behavior. Pharmacol Biochem. Behav. 51: 545-547, 1995.
4. 3 receptor-selective ligand. 7-OH-DPAT. in the normal and the reserpine-treated rat. Eur. J. Pharmacol. 260: 177- 181, 1994.
5. 3 receptor agonist ligand. to CHO-KI cells. Life Sci. 57: 1401-1410, 1995.
6. 3 receptor agonists on pilocarpine-induced limbic seizures in the rat. Neuroscience 60: 1039-1047, 1994.
7. 3-receptor agonist, on nucleus accumbens neurons. Jpn. J. Pharmacol. 65: 293-295, 1994.
8. 3-preferring ligands act at synthesis modulating autoreceptors. J. Pharmacol. Exp. Ther. 274: 609-613, 1995.
9. 3 subtypes. Brain Res. 649: 95-110, 1994.
10. 3 receptor gene in schizophrenia. Mol. Psych. 1: 125-132, 1996.
11. 3 dopamine receptor, in rat brain: a receptor binding and quantitative autoradiographic study. Neuropsychopharmacology (in press).
12. 3 receptors in the cerebellum. Brain Res. 737: 347-350, 1996.
13. REVINS, R. A., DELZER, T. A., AND BARDO, M. T.: Characterization of conditioned taste aversion produced by 7-OH-DPAT in rats. Pharmacol. Biochem. Behav 53: 695-699, 1996.
14. 125I|-iodosulpride. Synapse 19: 1-13, 1995.
15. 2 receptor mRNA. Brain Res. 564: 203-219, 1991.
16. BOWERY, B., ROTHWELL, L. A., AND SEABROOK, G. R.: Comparison between the pharmacology of dopamine receptors mediating the inhibition of cell firing. in rat brain slices through the substantia nigra pars compacta and ventral tegmental area. Br. J. Pharmacol. 112: 873-880, 1994.
17. 3 receptors, expressed in the same cell line, using the cytosensor microphysiometer. Biochem. Soc. Trans. 24: S57, 1996.
18. 3 receptor gene in Tourette's syndrome. Lancet 341: 1225, 1993.
19. 5 receptors, dopamine beta hydroxylase, tyrod nase. and tyrosine hydroxylase. Biol. Psychiatry 37: 533-540, 1995.
20. 3 receptor mRNA levels in rat brain following antipsychotis treatment. Psychopharmacol, Ser. (Berl.) 106: 479-483, 1992.
21. 3 receptor mRNA levels. Neuropharmacology 32: 901-907, 1993.
22. 2 dopamine receptor cDNA. Nature (Lond.) 336: 786-787, 1988.
23. 3 receptors in rat olfactory tubercle. J. Pharmacol. Exp. Ther. 268: 935-942, 1994.
24. 3 dopamine receptors. Neuropsychopharmacology 12: 335-345, 1995.
25. 3 dopamine receptor gene expression in the rat forebrain: detection by reverse polymerase chain reaction. Neurosci. Lett. 155: 92-95, 1993.
26. 2 dopamine receptor agonists and antagonists on prepulse inhibition of acoustic startle in the rat. Neuropsychopharmacology 12: 139-145, 1995.
27. CAINE, S. B., AND KOOB, G. F.: Modulation of cocaine self-administration in the rat through D-3 dopamine receptors. Science 260: 1814-1816, 1993.
28. 2 receptors in the brain of several mammalian species. J. Neural Transm. 43: 283-287, 1990.
29. 3 dopamine receptors to G-proteins. FEBS Lett 315: 223-226, 1993.
30. 3 receptor gene: some preliminary considerations. Am. J. Med. Genet. 54: 253-255, 1994.
31. 3 receptor preferring ligands on the acquisition of place conditioning in rats. Behav. Pharmacol. 7: 105-109, 1996.
32. 2 dopamine receptors. Mol. Pharmacol. 45: 51-60, 1994.
33. 3 receptors. J. Med. Chem. 37: 4245-4250, 1994.
34. COON, H., BYERLY, W., HOIK, J., HOFF, M., MYLES-WORSLEY, M., LANNFELT, L., SOKOLOFF, P., SCHWARTZ, J.-C., AND WALDO, M.: Linkage analysis of schizophrenia with five dopamine receptor genes in nine pedigrees. Am. J. Hum. Genet. 52: 327-334, 1993.
35. 3R receptor knockout mice. (Abstract) Soc. Neurosci. Abst. 22: 1319, 1996.
36. 3 receptor. Synapse 21: 1-9, 1995.
37. 3 dopamine receptor gene. J Med. Genet. 29: 858-860, 1992.
38. CURRAN, E. J., AND WATSON, S. J., JR.: Dopamine receptor mRNA expression patterns by opioid peptide cells in the nucleus accumbens of the rat: a double in situ hybridization study. J. Comp. Neurol. 361: 57-76, 1995.
39. 2 receptor: two molecular forms generated by alternative splicing. EMBO J. 8: 4025-4034, 1989.
40. DALY, S. A., AND WADDINGTON, J. L.: Behavioural effects of the putative D-3 dopamine receptor agonist 7-OH-DPAT in relation to other "D-2-like" agonists. Neuropharmacology 32: 509-510, 1993.
41. 3 receptor ligand. Eur. J. Pharmacol. 249: R9-R10, 1993.
42. 2 dopamine receptors. Biochemistry 32: 8179-8183, 1993.
43. 3 receptors in the mouse brain: autoradiographic evidence for a transient cortical expression. Dev. Brain Res. 94: 166-174, 1996.
44. 3 receptor agonist 7-OH-DPAT: comparison with quinpirole and apomorphne. Psychopharmacology 124: 231-240, 1996.
45. DEVOTO, P., COLLU, M., MUNTONI, A. L., PISTIS, M., SERRA, G., GESSA, G. L., AND DIANA, M.: Biochemical and electrophysiological effects of 7-OH-DPAT on the mesolimbic dopaminergic system. Synapse 20: 153-155, 1995.
46. 3 receptor in an Italian psychotic population. Psychiatr. Genet. 4: 39-42, 1994.
47. 3 receptors on neurotensin mRNA expression in nucleus accumbens. Eur. J. Neurosci. 6: 1384-1387, 1994.
48. 3 receptor in the rat brain. Neuroscience 65: 731-745, 1995.
49. 4 receptor genes and schizophrenia defined by several diagnostic systems. Biol. Psychiatry 40: 419-421, 1996.
50. 3 receptor agonist 7-OH-DPAT in rats. Pharmacol. Res. 32: 63-68, 1995.
51. 3 dopamine receptors in murine embryonic development. FEBS Lett. 381: 257-361, 1996.
52. 3 dopamine receptor generated by alternative splicing in the third cytoplasmic loop. J. Biol. Chem. 268: 5872-5878, 199:1
53. 2 dopamine receptor subtype mRNA levels in the brain. FEBS Lett. 339: 63-66, 1994.
54. a-selective drugs in rat brain. (Abstract) Soc. Neurosci. Abst. 22: 827, 1996.
55. Fox, C. A., MANSOUK, A., AND WATSON, S. J., JR.: The effects of haloperidol on dopamine receptor gene expression. Exp. Neurol. 130: 288-303, 1994.
56. a receptor and 7-OH-DPAT. Trends Pharmacol. Sci. 15: 173-174, 1994a.
57. 3 dopamine receptor J. Pharmacol. Exp. Ther. 286: 417-426, 1994b.
58. 3) alleles and cocaine dependence. Addiction Biol. 1: 281-287, 1996.
59. 3 receptor gene: an additional intron and an mRNA variant. DNA Cell Biol. 14: 485-492, 1995.
60. 3 receptor in the presynaptic regulation of dopamine release but not synthesis. Eur. J. Pharmacol. 308: 261-269, 1996.
61. 3 dopamine receptor Mscl polymorphism with sehizophrenia: analysis of symptom ratings, family history, age at onset, and movement disorders. Am. J. Med. Genet. 67: 455-458, 1996.
62. 3H]quinpirole binding sites in the rat brain. Synapse 14: 113-120, 1992.
63. 3 receptors in rat brain. Eur. J. Pharmacol. 211: 189-194, 1992.
64. GHEZ, C., AND FAHN, S.: The cerebellum. In Principles of Neural Science, ed. by E. R. Kandel and J. H. Schwartz. pp. 334-346. Elsevier/North-Holland, New York, 1981.
65. 3 auzoreceptor-mediated effects? Pharmacol. Biochem. Behav. 52: 275-280, 1995.
66. 3 agonist, 7-OH-DPAT, reduces dopamine release in the nucleus accumbens and electrical self-stimulation to the ventral tegmentum. Brain Res. 681: 1-7, 1995.
67. 2 dopamine receptor isoforms. Nature (Lond.) 142: 923-926, 1989.
68. 3 dopamine receptor produced through various patterns of alternative splicing. Biochem. Biophys. Res. Commun. 176: 1584-1592, 1991.
69. 3 humain et identification de son chromosome, C. R. Acad. Sci. III 311: 501-508, 1990.
70. 3 receptor agonist, 7-hydroxy-N,N-di-n-propyl-2-aminotetralin. reduces gastric acid and pepsin secretion and experimental gastric mucosal injury in rats. Life Sci. 56: 287-293, 1994.
71. 3 autoreceptors control synthesis and release in mesolimbic, mesocortical and nigrostriatal pathways. J. Pharmacol Exp Ther. 275: 899-913, 1995.
72. 3 receptors. Eur. J. Pharmacol. 272: R1-R3, 1995.
73. 3 dopamine receptor gene in three independent samples. Am. J. Med. Genet. 60: 529-531, 1995.
74. 3 receptor gene: organiza- tion, transcript variants, and polymorphism associated with schizophrenia. Am. J. Med. Genet. 67: 63-70, 1996.
75. 3 receptor ligand, (+)-UH232, is a partial agonist Eur. J. Pharmacol. 282: R3-R4, 1995.
76. 2 dopamine receptors from the high- to low-affinity state for dopamine agonists using sodium ions and guanine nucleotides. J. Neurochem. 44: 1925-1935, 1985.
77. 3H]7-hydroxy-N,N-di-n-propyl-2-aminotetralin. Brain Res. 648: 222-228, 1994.
78. HIGUCHI, S., MURAMATSU, T., ARAI, H., HAYASHIDA, M., SASAKI, H., AND TROJANOWSKI, J. Q.: Polymorphisms of dopamine receptor and transporter genes and Parkinson's disease. J. Neural Transm. Parkinson's Dis. Dementia Sect. 10: 107-113, 1995.
79. 3 receptor locus and alcoholism in the Japanese. Am. J. Med. Genet. 67: 412-414, 1996.
80. HULME, E. C., BIROSALL, N. J. M., AND BCCKLEY, N. J.: Muscarinic receptor subtypes Ann. Rev. Pharmacol. Toxicol. 30: 633-673, 1990.
81. 3 receptor expression within the basal ganglia is not affected by Parkinson's disease. Neurosci. Lett. 214: 75-78, 1996.
82. 3 receptor gene. Acta Psychiatr. Scand. 87: 543-549, 1993.
83. JONSSON, E., SEDVALL, G., BRENE, S., GUSTAVSSON, J. P., GEIJEH, T., TERENIUS, L., CROCQ, M. A., LANNFELT, L., TYLEC, A., SOKOLOFF, P., SCHWARTZ, J. C., AND WIESEL, F. A.: Dopamine related genes and their relationships to monoamine metabolites in CSF. Biol. Psychiatry 40: 1032-1043, 1996.
84. 3 agonists disrupt social behavior in rats. Brain Res. 721: 229-232, 1996.
85. KENAKIN, T.: The classification of seven transmembrane receptors in recombinant expression systems. Pharmacol. Rev. 48: 413-463, 1996.
86. 3 receptor gene and schizophrenia. Am. J. Med. Genet. 60: 558-562, 1995.
87. 3-preferring agonist 7-OH-DPAT on motor behaviors and place conditioning. Psychopharmacology 122: 351-357, 1995.
88. KLINO-PETERSEN, T., LJUNG, E., AND SVENSSON, K.: The preferential dopamine autoreceptor antagonist (+)-UH232 antagonizes the positive reinforcing effects of cocaine and d-amphetamine in the ICSS paradigm. Pharmacol. Biochem. Behav 49: 345-351, 1994.
89. 3 preferring compounds in discrete areas of the rat brain J. Neural Transm. Gen. Sect. 102: 209-220, 1995.
90. 3 receptor deficient mice. (Abstract) Soc. Neurosci. Abst. 21: 364, 1995.
91. 3 receptor binding affinities. Eur. J. Pharmacol. 277: 209-214, 1995.
92. 3 dopamine receptors. Cell. Mol. Neurobiol. 14: 185-191, 1994.
93. 125I]R(+)trans-7-OH-PIPAT in rat brain. Naunyn-Schmiedeberg's Arch. Pharmacol. 350: 611-617, 1994.
94. 3 receptor agonists, 7-OH-DPAT, and quinpirole, on yawning, stereotypy, and body temperature in rats. Pharmacol Biochem. Behav 52: 503-508, 1995.
95. 2-family receptor distribution in human post-mortem tissue: an autoradiographic study. NeuroRe-port 6: 2505-2512, 1995.
96. 3 receptor agonist 7-OH-DPAT in rhesus monkey trained to discriminated cocaine from saline. Psychopharmacology 124: 306-314, 1996.
97. 3 receptor sites in rat brain: a comparative study using in situ hybridization histochemistry and ligand binding autoradiography. Eur. J. Neurosci. 5: 145-153, 1993a.
98. 3 receptor mRNA and binding sites in human brain. Mol. Brain Res 18: 187-192, 1993b.
99. 3 receptor as a useful polymorphism for investigating psychiatrie disorders Psychiatr Genet. 2: 249-256, 1992.
100. 3 receptor: Chinese hamsters or Chinese whispers? Trends Pharmacol. Sci. 15: 46-47, 1994.
101. 2 dopamine receptors: visualization of cellular expression patterns in motor and limbic structures. Synapse 200, 325-337, 1995.
102. 3 dopamine receptor gene. Hum. Genet. 87: 618-620, 1991.
103. LEFKOWITZ, R. J., AND CARON, M. G.: Adrenergic receptors. Models for the study of receptors coupled to guanine nucleotide regulatory proteins. J. Biol Chem. 253: 4993-4996, 1988.
104. 3 autoreceptors inhibits firing of ventral tegmental dopaminergic neurones in vivo. Eur. J. Pharmacol 275: R7-R9, 1995.
105. 3H]7-OH-DPAT-labeled binding sites in rat brain to inactivation by N-ethoxycarbonyl-2-ethoxy-l,2-dihydroquino-line. Brain Res 698: 146-154, 1995.
106. LEVANT, B.: Distribution of dopamine receptor subtypes in the CNS. In CNS Neurotransmitters and Neuromodulators: Dopamine, ed. by T. W. Stone, pp. 77-87, CRC Press, Boca Raton. Florida, 1996.
107. 2 dopamine receptors by 7-OH-DPAT. Synapse 24: 60-64, 1996.
108. 3 receptors. Synapse 14: 90-95, 1993.
109. 2-like dopamine receptors in rat brain. J. Pharmacol. Exp. Ther. 262: 929-935, 1992.
110. 3 dopamine receptors in rat brain and pituitary gland: a quantitative autoradiographic study. J. Pharmacol. Exp. Ther. 264: 991-1001, 1993.
111. 3 dopamine receptors. Eur. J. Pharmacol. 278: 243-247, 1995
112. 2 dopamine receptors by nafadotride. Neuropsychopharmacology 17: 67-71, 1997.
113. 3H]hydroxy-n,n-di-n-propyl-2-aminotetralin. Proc. Natl. Acad. Sci. USA 89: 8155-8159, 1992.
114. 3 receptor expression suggests the involvement of an anterograds factor from dopamine neurons. Proc. Natl. Acad. Sci. USA 92: 1719-1723, 1995.
115. 3 receptor agonist 7-OH-DPAT: lack of mesolim selectivity. Eur. J. Pharmacol 264: 269-278, 1994a
116. 3nf-like immunoreactivity in human brain. J. Biol. Chem. 269: 29239-29226, 1994b.
117. 2 dopamine receptors stably transfected into NG108 15 cells couple to-a voltage dependent potassium current via distinct g protein mechanism Synapse 24: 156-164, 1996.
118. 3 receptor binding by N-ethylmaleimide and neurotensin. Brain Res. 643: 343-348, 1994c.
119. 2-like dopamine receptors. Biochem. J. 287: 277-282, 1992.
120. LUNDSTROM, K., AND TURPIN, M. P.: Proposed schizophrenia related polymorphism: expression of the Ser9Gly mutant human dopamine receptor with the Semliki Forest virus system. Biochem. Biophys. Commun. 225: 1068-1072, 1996.
121. 4 using haplotype relation risk. Hum. Hered. 44: 328-336, 1994.
122. 3 receptor expressed in transfected cell lines. J Pharmacol 266: 79-85, 1994.
123. 3 receptors. Mol. Pharmacol. 43: 749-754, 1993.
124. 3 receptors. Mol. Pharmacol. 46: 299-312, 1994.
125. 4 receptor and transporter gene polymorphisms and mood disorders. J. Affect. Disord. 40: 7- 13, 1996.
126. 3 receptor gene and schizophrenia. Am. J. Med. Genet. 54: 21-26, 1994.
127. 3 /D., dopamine receptor expressed in CHO cells. FEBS Lett. 324: 81-86, 1993.
128. MCELROY, J., ZELLER, K. L., AMY, K. A., WARD, K. A., CAWLEY, J. F., MAZZOLA, A. L., KEIM, W., AND ROHRBACH. K.: In neu agonist properties of 7-hydroxyN,N-Di-N-propvl-2-aminotetralin. a dopamine D-selective receptor ligand. Drug Dev. Res 30: 207-259, 1993.
129. MEADOR-WOODRUFF, J. H., GRANDY, D. K., VAN TOL, H. H., DAMASK. S. P., LITTLE, K. Y., CIVELLI, O., AND WATSON, S. J., JR.: Dopannne receptor gene expression in the human medial temporal lobe Neuropsychopharmacology 10: 239-248, 1994.
130. 4 receptor expression in the human striatum. Biol. Psychiatr 38: 263-266, 1995.
131. MEERT, T. F. AND GLINCKE, G. H.: 7-OH-DPAT and alcohol consumption, withdrawal and discriminative stimulus properties in rats. Alcohol 29: 489-492, 1994
132. 3 receptor mHNAs in human and rat brain. N'eurochem, Int. 20(Suppl): 33s-43s, 1992.
133. 3 receptors. Cerebral Cortex 6: 561-570, 1996.
134. 4 receptors. Eur. J. Pharmacol. 290: 29-36, 1995.
135. 3 receptors participate in clozapine-induced hypothermia. Eur. J. Pharmacol 280: 220-229, 1995a.
136. 3 receptors blocks 7-OH-DPAT-induced hypothermia in rats. Eur. J. Pharmacol, 260: R3-R3, 1994.
137. 2 receptors elicits prolactin secretion and catalepsy, J. Pharmacol. Fxp. Ther. 275: 885-898, 1995b.
138. 3 receptor gene in nine Australian pedigrees, J. Affect. Disord. 27: 213-224, 1993.
139. 1 receptor linked to adenylyl cyclase activation. Proc. Natl. Acad. Sci. USA 87: 6723-6727, 1990.
140. 125I]lepidepride. Eur, J. Pharmacol. 227: 443-145, 1992.
141. 2 receptors to mesostriatal regions of human forebrain Proc. Natl. Acad. Sci. USA 91: 11271-11275, 1994.
142. 3 dopamine receptor mRNA expression in lymphocytes from patients with Parkinson's disease. Neurology 46: 791-795, 1996.
143. 3 dopamine receptor gene and a novel variant transcript generated by alternative splicing in human peripheral blood lymphocytes. Biochem. Biophys Res. Commun. 194: 368-374, 1993.
144. 4 receptor gene loci in four Japanese pedigrees. Psychiatry Res. 52: 149-157, 1994a.
145. 3 receptor gene locus. Am. J. Med. Genet. 54: 264-267, 1994b.
146. 3 receptor gene. Hum. Genet. 92: 336338, 1993.
147. 4 receptor gene polymorphisms. Am. J. Med. Genet 54: 361-364, 1994c.
148. 3 receptor gene locus in two independent samples Am. J. Med. Genet. 67: 505-014, 1996.
149. 3 receptor gene polymorphisms: probable effects of family history of schizophrenia? Am. J. Med. Gnet. 48: 214-217, 1993.
150. 3 receptor antisense influences dopamine synthesis in rat brain. Neuroreport 6: 573-576, 1995.
151. 3 dopamine receptor Biochem. Soc. Trans 22: 143s, 1994.
152. 4 receptors. J. Pharmacol. Exp Ther. 277: 186-192, 1996.
153. 3 receptor gene giving rise to an mKNA isoform expressed in rat brain. Biochem. Biophys. Res. Commun. 194: 465-471, 1993.
154. 3 dopamine receptor gene. J. Neurochem. 64: 482-486, 1995.
155. 3 receptor gene and bipolar affective disorder. Am. J. Med. Genet. 60: 234-237, 1995.
156. 3 receptors in rat brain. Eur. J. Pharmacol. 234: 269-272. 1993.
157. PATEL, J., TROUT, S. J., PALIJ, P., WHRLPTON, R., AND KRUK, Z. L.: Biphasic inhibition of stimulated endogenous dopamine release by 7-OH-DPAT in slices of rat nucleus accumbens. Br. J. Pharmacol. 115: 421-426, 1995.
158. 3 receptor in a transfected NG 108-15 neuroblastoma-ghoma hybrid cell line. Eur. J. Pharmacol. 268: 129-139, 1994.
159. 3 receptors: a computerized study in rabbits. Life Sci. 59: 1755-1761, 1996.
160. 3 dopamine receptors. J. Neurosci. 14: 1463-1476, 1994.
161. 3 agonist PD 128907. J. Pharmacol. Exp. Ther. 275: 1355-1366, 1995.
162. 3 receptor in rat cerebellar cortex: a light microscopic autoradiographic study. Neurosci Lett. 190: 163-166, 1995.
163. 2 receptors in rat central nervous system Neuroscience 30: 767-777, 1989.
164. 3 receptor Gly(9)/Ser(9) polymorphism and schizophrenia: no increased frequency of homozygosity in German familial cases. Schizophr. Res. 20: 181-186, 1996.
165. 3 receptor protein: no role in the genetic predisposition to bipolar affective disorder. Psychiatry Res. 46: 253-259, 1993.
166. 3 receptor antagonist, (-)-S 14297. Eur. .J. Pharmacol. 265: 175-177, 1994.
167. 1 receptor: chimeric receptors delineate a role for intracellular domains. Mol. Pharmacol 46: 352-356, 1994.
168. 3-receptor agonist 7-OHDPAT. Pharmacol. Biochem. Behav. 54: 79-84, 1996.
169. KODRIUEZ DE FONSKCA, F., RUBIO, P., MARTIN CALDERON, J. L., CAINE, S. B., KOOB, G. F., AND NAVARRO, M.: The dopamine receptor agonist 7-OH-DPAT modulates the acquisition and expression of morphine-induced place preference. Eur. J. Pharmacol. 274: 47-55, 1995.
170. SABATÉ, O., CAMPION, D., D'AMATO, T., MARTRES, M. P., SOKOLOFF, P., GIROS, B., LEBOYER, M., JAY, M., GUENJ, F., THIBAUT, F., AND AL., E.: Failure to find evidence for linkage or association between the dopamine D, receptor gene and schizophrenia. Am. J. Psychiatry 151: 107-111, 1994.
171. 3 receptor gene polymorphism (balI) in Chinese schizophrenic males Psychiatr. Genet. 4: 201-204, 1994.
172. 3, receptors in the effects of dopamine agonists on operant behavior in rats. Behav Pharmacol. 7: 477-482, 1906.
173. 2 receptors. Neuroreport 6: 329-332, 1995a.
174. 3 receptor antagonist, activates locomotion in rodents. J. Pharmacol Exp. Ther. 275: 1239-1246, 1995b.
175. 3 type receptor mKNA expression in parietal and motor cortices of patients with chronic schizophrenia. Proc. Natl. Acad Sci. USA 90: 8942-8946, 1993.
176. 3 receptors and sigma sites in the bovine caudate nucleus. Eur. J. Pharmacol. 242: R1-R2, 1993.
177. 3 receptors in vivo. Eur. J. Pharmacol. 218: 373-375, 1992.
178. 3 dopamine receptors in differentiated neuroblastoma × glioma NG108-15 cells. Br. J. Pharmacol. 111: 391-393, 1994.
179. 1 pituitary cells. FEBS Lett. 312: 123-126, 1992.
180. SEEMAN, P.: Brain dopamine receptors. Pharmacol Rev. 32: 229-318, 1981.
181. 4 receptors elevated in schizophrenia. Nature (Lond.) 365: 441-445, 1993.
182. SEEMAN, P., AND GRICORIADIS, D. E.: Dopamine receptors in brain and periphery. Neurochem. Int. 10: 1-25, 1987.
183. 3 receptor gene: no association with bipolar affective disorder. J. Med. Genet. 30: 308-309, 1993.
184. 3 receptor gene and schizophrenia. Hum. Genet. 97: 714-719, 1996.
185. SIBLEY, D. R., AND OREESE, I.: Regulation of ligand binding to pituitary D-2 dopamincrgic receptors. J. Biol. Chem. 258: 4957-4965, 1983.
186. SIBLEY, D. R., MONSMA, K. J., AND SHKN. Y.: Molecular neurobiology of dopaminergic receptors. Int. Rev. Neurobiol. 35: 391-415, 1993.
187. 3 receptor. Biochem. Biophys. Res. Commun. 180: 1031-1035, 1991.
188. 3) as a target for neuroleptics. Nature (Lond) 347: 146-151, 1990.
189. 2 receptor Eur. J. Pharmacol. 225: 331-337, 1992.
190. 3, DAT1. and TH genes. Am. J. Med. Genet. 67: 551-555, 1996.
191. 3 dopamine receptors in the brain reward circuits of human cocaine fatalities. J. Neurosci. 16: 6100-6106, 1996.
192. 3 receptors, Eur. J. Pharmacol. 277: 151-158, 1995.
193. 1. Nature (Lond.) 350: 614-619, 1991.
194. 3 receptors. Eur. J. Pharmacol 263: 235-243. 1994 a.
195. SVENSSON, K., CARLSSON, A., AND WATERS, N.: Locomotor inhibition by the D, ligand R (-)-7-OH-DPAT is independent of changes in dopamine release. J. Neural Transm. Gen. Sect. 95: 71-74, 1994b.
196. 4 dopamine receptors rvealed in transfected neuronal cell lines. Proc. Natl. Acad. Sci. USA 91: 649-653, 1994.
197. a receptor gene polymorphism. Am. J. Med. Genet. 6: 366-368, 1996.
198. 4 dopamine receptor in fibroblast and dopaminergic cell lines. J. Pharmacol. Exp. Ther. 268: 495-502, 1994a.
199. 3 receptors inhibit dopamine release. J. Pharmacol. Exp. Ther. 270: 475-479, 1994b.
200. 2 receptor stimulation enhances neurite outgrowth. Biol. Psychiatry 31: 794-807, 1992.
201. 3, receptor mRNA in midgestational human fetal cortex by situ hybridization, (Abstract) Soc. Neurosci. Abst. 19: 1111, 1993.
202. 1 mRNA in midgestational human forebrain by in situ hybridization. (Abstract) Soc. Neurosci. Abst. 21: 1995.
203. 3 receptor-mediated increase in the release of oxytocin in the male rat. Neuroreport 6: 1338-1340, 1995.
204. 1 receptor mRNA levels in rat brain and pituitary during aging. Neurobiol. Aging 15: 713-719, 1994.
205. 2 receptor. Trends Pharmacol. Sci. 10: 74- 77, 1989.
206. 2 receptor functionally coupled to adenylyl cyclase in Chinese hamster ovary cells Mol Pharmacol. 48: 3.14-351, 1995.
207. 4 receptor with high affinity for the antipsychotic clozapine Nature (Lond.) 350: 610-614, 1991.
208. 2 like dopamine receptors are not detectable on human peripheral blood lymphocytes. Biol. Psychiatry 40: 881-885, 1999.
209. 3H|propyl-2-aminotetralin and carbetapentane. J. Neurochem. 64: 700-710. 1995.
210. 3 dopamine recepto mRNA by neuroleptics. Synapse 23: 232-235, 1996.
211. 3 receptor antagonists in regard to dopamine release, in vivo receptor displacement and behavior. J. Neural Transm. Gem. Sect. 98: 39-55, 1994.
212. 3-receptor: a postsynaptic receptor inhibitory on rat locomotor activity. J. Neural Transm. Gen. Sect. 94: 11-19, 1993.
213. 4 dopamine receptors couple to G protein-regulated potassium channels in Xenopus oocytes. Mol. Pharmacol. 49: 656-661, 1996.
214. 3-dopamine receptor gene locus in Icelandic pedigrees. Psychiatry Res 46: 69-78, 1993.
215. 3 dopamine receptors in insect cells using the baculovirus system. Biochem. Soc. Trans. 23: 93s, 1995.
216. 1 receptor mutant mice. (Abstract) Soc. Neurosci. Abst. 21: 363, 1995.
217. YAMAHA, S., YOKOO, H., AND NISHI, S: Differential effects of dopamine agonists on evoked dopamine release from slices of striatum and nucleus aecumbens in rats. Brain Res. 648: 176-179, 1994.
218. 3 dopamine receptor gene. Am. J. Med. Genet. 48: 83-86, 1993.
219. 3 receptor agonist, 7-OH-DPAT, causes vomiting in the dog. Life Sci. 57: P1347-P1350, 1995.
220. 1 dopamine receptors. Nature (Lond) 347: 72-76, 1990. 1